Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04672096Not ApplicableCompleted

Basic Assessment of Safety and Minimally Invasive Stimulation Via Injectrode

Role: collaborator

NCT06206356Phase 1Completed

Lumbar Injectrode Feasibility Evaluation

Role: collaborator

NCT03756012Not ApplicableCompleted

Evaluation of Clinical Outcomes of Pulse Widths in Spinal Cord Stimulation

Role: collaborator

All 3 trials loaded